2021 annual financial data
Editas Medicine 2021 Operating cash flow
Editas Medicine 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -163,803,000 USD.
Operating income was -193,146,000 USD and net income was -185,107,000 USD.
Operating cash flow was -163,803,000 USD.
Get free Editas Medicine email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,544,000 USD
- Operating income
- -193,146,000 USD
- Net income
- -185,107,000 USD
- Operating cash flow
- -163,803,000 USD